Michael Gelband’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-41,360
| Closed | -$2.92M | – | 1868 |
|
|
2026
Q1 | $2.92M | Sell |
41,360
-229,323
| -85% | -$17.2M | 0.02% | 626 |
|
|
2025
Q4 | $21.4M | Buy |
+270,683
| New | +$21.4M | 0.17% | 97 |
|
|
2025
Q3 | – | Sell |
-111,456
| Closed | -$8.96M | – | 1834 |
|
|
2025
Q2 | $8.96M | Buy |
+111,456
| New | +$8.6M | 0.08% | 261 |
|
|
2024
Q4 | – | Sell |
-31,115
| Closed | -$2.57M | – | 1835 |
|
|
2024
Q3 | $2.57M | Sell |
31,115
-123,347
| -80% | -$9.21M | 0.02% | 637 |
|
|
2024
Q2 | $10.8M | Buy |
+154,462
| New | +$11M | 0.07% | 240 |
|
|
2024
Q1 | – | Sell |
-54,152
| Closed | -$3.58M | – | 1782 |
|
|
2023
Q4 | $3.58M | Buy |
+54,152
| New | +$3.39M | 0.02% | 423 |
|
|
2023
Q3 | – | Sell |
-144,593
| Closed | -$8.17M | – | 1960 |
|
|
2023
Q2 | $8.17M | Sell |
144,593
-28,198
| -16% | -$1.56M | 0.07% | 295 |
|
|
2023
Q1 | $10M | Buy |
172,791
+102,000
| +144% | +$6.88M | 0.08% | 281 |
|
|
2022
Q4 | $5.12M | Sell |
70,791
-91,669
| -56% | -$6.57M | 0.07% | 350 |
|
|
2022
Q3 | $9.87M | Buy |
+162,460
| New | +$10.4M | 0.13% | 205 |
|
|
2022
Q2 | – | Sell |
-25,506
| Closed | -$1.79M | – | 2237 |
|
|
2022
Q1 | $1.79M | Sell |
25,506
-30,892
| -55% | -$2.09M | 0.02% | 836 |
|
|
2021
Q4 | $3.52M | Sell |
56,398
-23,789
| -30% | -$1.49M | 0.04% | 553 |
|
|
2021
Q3 | $4.95M | Sell |
80,187
-146,609
| -65% | -$8.83M | 0.07% | 406 |
|
|
2021
Q2 | $13.6M | Buy |
226,796
+205,978
| +989% | +$13.1M | 0.15% | 96 |
|
|
2021
Q1 | $1.27M | Sell |
20,818
-50,651
| -71% | -$2.8M | 0.02% | 785 |
|
|
2020
Q4 | $3.35M | Sell |
71,469
-230,338
| -76% | -$9.98M | 0.03% | 361 |
|
|
2020
Q3 | $11.2M | Buy |
+301,807
| New | +$11.5M | 0.22% | 69 |
|
|
2020
Q2 | – | Sell |
-27,251
| Closed | -$833K | – | 1918 |
|
|
2020
Q1 | $833K | Sell |
27,251
-31,545
| -54% | -$1.4M | 0.05% | 343 |
|
|
2019
Q4 | $3M | Sell |
58,796
-380,294
| -87% | -$18.4M | 0.06% | 254 |
|
|
2019
Q3 | $20.7M | Buy |
+439,090
| New | +$20.9M | 0.72% | 23 |
|
|
2019
Q2 | – | Sell |
-11,939
| Closed | -$508K | – | 1248 |
|
|
2019
Q1 | $508K | Buy |
+11,939
| New | +$528K | 0.04% | 331 |
|
Other funds holding MET
Michael Gelband's MET Position: Q2 2026 in Review
Michael Gelband sold out of MetLife (MET) in Q2 2026, closing a stake of 41,360 shares — an estimated $2.92M sold.
Michael Gelband first reported a position in MET in Q1 2019 and held it in 21 quarters. The position peaked at $21.4M in Q4 2025. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Michael Gelband reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
- Michael Gelband sold 41,360 MetLife shares in Q2 2026, an estimated $2.92M.
- Michael Gelband first reported a position in MetLife in Q1 2019 and held it in 21 quarters.
- Michael Gelband's MetLife position peaked at $21.4M in Q4 2025.
- 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.